Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Accelerate Diagnostics Inc. (AXDX)

22.55 0.4 (1.81%)

09-21 16:00

Open:

22.25

Pre. Close:

22.15

High:

22.65

Low:

21.9

Volume:

294,140

Market Cap:

1221M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.571 - 22.68

22.68 - 22.775

Low:

21.591 - 21.716

21.716 - 21.824

Close:

21.962 - 22.157

22.157 - 22.324

Technical analysis  (as of: 2018-09-21 3:56:35 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 26.94     One year: 28.91

Support:

Support1: 20.35    Support2: 16.93

Resistance:

Resistance1: 23.07    Resistance2: 24.75

Pivot:

22.35

Moving Averages:

MA(5): 22.01     MA(20): 22.71

MA(100): 21.88     MA(250): 23.51

MACD:

MACD(12,26): -0.17     Signal(12,26,9): -0.10

%K %D:

%K(14,3): 41.29     %D(3): 39.77

RSI:

RSI(14): 49.45

52-Week:

High: 30.35  Low: 16.75  Change(%): -0.7

Average Vol(K):

3-Month: 18152  10-Days 19175

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AXDX has closed above bottom band by 47.7%. Bollinger Bands are 27.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-08-07T07:50:00-04:00
Accelerate Diagnostics Receives New Innovative Technology Contract from Vizient for the Accelerate Pheno(TM) System

2018-08-06T21:45:52-04:00
Accelerate Diagnostics, Inc. (AXDX) CEO Lawrence Mehren on Q2 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostics Research

Shares Out. (M)

54.13

Shares Float (M)

50.23

% Held by Insiders

% Held by Institutions

35.30

Shares Short (K)

13099

Shares Short Prior Month (K)

Stock Financials

EPS

-1.380

EPS Est. Current Year

-1.200

EPS Est. Next Year

-0.980

EPS Est. Next Quarter

-0.310

Forward EPS

-0.730

Book Value (p.s.)

11.870

PEG Ratio

-0.49

Profit Margin

Operating Margin

-1373.00

Return on Assets (ttm)

-41.9

Return on Equity (ttm)

-64.5

Qtrly Rev. Growth

142.1

Gross Profit (p.s.)

0.039

Sales Per Share

EBITDA (p.s.)

-0.600

Qtrly Earnings Growth

Operating Cash Flow (M)

-63.07

Levered Free Cash Flow (M)

-36.34

Valuation

P/E

-16.12

P/E Growth Ratio

P/BV

1.87

P/S

12043924480.00

P/CF

-19.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.